Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Agile Therapeutics Market Cap 2013-2023 | AGRX

Agile Therapeutics market cap history and chart from 2013 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Agile Therapeutics market cap as of May 09, 2024 is $0B.
  
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.003B $0.020B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $17.646B 6.15
Dr Reddy's Laboratories (RDY) India $11.932B 17.74
Aspen Pharmacare (APNHY) South Africa $5.386B 0.00
BridgeBio Pharma (BBIO) United States $5.183B 0.00
Bausch Health Cos (BHC) Canada $2.579B 1.96
Amphastar Pharmaceuticals (AMPH) United States $2.030B 12.41
Supernus Pharmaceuticals (SUPN) United States $1.721B 0.00
Taysha Gene Therapies (TSHA) United States $0.445B 0.00
Generation Bio (GBIO) United States $0.206B 0.00
Personalis (PSNL) United States $0.079B 0.00
Assembly Biosciences (ASMB) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00